BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 20056589)

  • 1. The implications of using a physiologically based pharmacokinetic (PBPK) model for pesticide risk assessment.
    Lu C; Holbrook CM; Andres LM
    Environ Health Perspect; 2010 Jan; 118(1):125-30. PubMed ID: 20056589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of chlorpyrifos and 3,5,6-trichloro-2-pyridinol in rat saliva after chlorpyrifos administration.
    Smith JN; Wang J; Lin Y; Klohe EM; Timchalk C
    Toxicol Sci; 2012 Dec; 130(2):245-56. PubMed ID: 22874420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative chlorpyrifos pharmacokinetics via multiple routes of exposure and vehicles of administration in the adult rat.
    Smith JN; Campbell JA; Busby-Hjerpe AL; Lee S; Poet TS; Barr DB; Timchalk C
    Toxicology; 2009 Jun; 261(1-2):47-58. PubMed ID: 19397948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers of chlorpyrifos exposure and effect in Egyptian cotton field workers.
    Farahat FM; Ellison CA; Bonner MR; McGarrigle BP; Crane AL; Fenske RA; Lasarev MR; Rohlman DS; Anger WK; Lein PJ; Olson JR
    Environ Health Perspect; 2011 Jun; 119(6):801-6. PubMed ID: 21224175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of chlorpyrifos exposure and absorbed daily doses among infants living in an agricultural area of the Province of Jiangsu, China.
    Liu P; Wu CH; Chang XL; Qi XJ; Zheng ML; Zhou ZJ
    Int Arch Occup Environ Health; 2014; 87(7):753-62. PubMed ID: 24257932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholinesterase inhibition in chlorpyrifos workers: Characterization of biomarkers of exposure and response in relation to urinary TCPy.
    Garabrant DH; Aylward LL; Berent S; Chen Q; Timchalk C; Burns CJ; Hays SM; Albers JW
    J Expo Sci Environ Epidemiol; 2009 Nov; 19(7):634-42. PubMed ID: 18716607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exposures of preschool children to chlorpyrifos and its degradation product 3,5,6-trichloro-2-pyridinol in their everyday environments.
    Morgan MK; Sheldon LS; Croghan CW; Jones PA; Robertson GL; Chuang JC; Wilson NK; Lyu CW
    J Expo Anal Environ Epidemiol; 2005 Jul; 15(4):297-309. PubMed ID: 15367928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of the chlorpyrifos metabolite 3,5,6-trichloro-2-pyridinol (TCPy) in rat saliva.
    Smith JN; Wang J; Lin Y; Timchalk C
    Toxicol Sci; 2010 Feb; 113(2):315-25. PubMed ID: 19920072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary exposure to chlorpyrifos and levels of 3,5,6-trichloro-2-pyridinol in urine.
    MacIntosh DL; Kabiru C; Echols SL; Ryan PB
    J Expo Anal Environ Epidemiol; 2001; 11(4):279-85. PubMed ID: 11571607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative pharmacokinetics of the organophosphorus insecticide chlorpyrifos and its major metabolites diethylphosphate, diethylthiophosphate and 3,5,6-trichloro-2-pyridinol in the rat.
    Timchalk C; Busby A; Campbell JA; Needham LL; Barr DB
    Toxicology; 2007 Jul; 237(1-3):145-157. PubMed ID: 17590257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Children's residential exposure to chlorpyrifos: application of CPPAES field measurements of chlorpyrifos and TCPy within MENTOR/SHEDS-Pesticides model.
    Hore P; Zartarian V; Xue J; Ozkaynak H; Wang SW; Yang YC; Chu PL; Sheldon L; Robson M; Needham L; Barr D; Freeman N; Georgopoulos P; Lioy PJ
    Sci Total Environ; 2006 Aug; 366(2-3):525-37. PubMed ID: 16360767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a pharmacokinetic model to assess chlorpyrifos exposure and dose in children, based on urinary biomarker measurements.
    Rigas ML; Okino MS; Quackenboss JJ
    Toxicol Sci; 2001 Jun; 61(2):374-81. PubMed ID: 11353146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnitude of behavioral deficits varies with job-related chlorpyrifos exposure levels among Egyptian pesticide workers.
    Anger WK; Farahat FM; Lein PJ; Lasarev MR; Olson JR; Farahat TM; Rohlman DS
    Neurotoxicology; 2020 Mar; 77():216-230. PubMed ID: 32006538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of in vivo nicotine exposure on chlorpyrifos pharmacokinetics and pharmacodynamics in rats.
    Lee S; Poet TS; Smith JN; Busby-Hjerpe AL; Timchalk C
    Chem Biol Interact; 2010 Mar; 184(3):449-57. PubMed ID: 20097188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exposures of preschool children to chlorpyrifos, diazinon, pentachlorophenol, and 2,4-dichlorophenoxyacetic acid over 3 years from 2003 to 2005: A longitudinal model.
    Wilson NK; Strauss WJ; Iroz-Elardo N; Chuang JC
    J Expo Sci Environ Epidemiol; 2010 Sep; 20(6):546-58. PubMed ID: 19724304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Derivation of human Biomonitoring Guidance Values for chlorpyrifos using a physiologically based pharmacokinetic and pharmacodynamic model of cholinesterase inhibition.
    Arnold SM; Morriss A; Velovitch J; Juberg D; Burns CJ; Bartels M; Aggarwal M; Poet T; Hays S; Price P
    Regul Toxicol Pharmacol; 2015 Mar; 71(2):235-43. PubMed ID: 25543108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics of chlorpyrifos in adult male Long-Evans rats following repeated subcutaneous exposure to chlorpyrifos.
    Ellison CA; Smith JN; Lein PJ; Olson JR
    Toxicology; 2011 Sep; 287(1-3):137-44. PubMed ID: 21708215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using physiologically-based pharmacokinetic models to incorporate chemical and non-chemical stressors into cumulative risk assessment: a case study of pesticide exposures.
    Wason SC; Smith TJ; Perry MJ; Levy JI
    Int J Environ Res Public Health; 2012 May; 9(5):1971-83. PubMed ID: 22754485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal assessment of occupational determinants of chlorpyrifos exposure in adolescent pesticide workers in Egypt.
    Callahan CL; Hamad LA; Olson JR; Ismail AA; Abdel-Rasoul G; Hendy O; Rohlman DS; Bonner MR
    Int J Hyg Environ Health; 2017 Nov; 220(8):1356-1362. PubMed ID: 28939184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of a source-to-outcome model for the assessment of health impacts from dietary exposures to insecticide residues.
    Price PS; Schnelle KD; Cleveland CB; Bartels MJ; Hinderliter PM; Timchalk C; Poet TS
    Regul Toxicol Pharmacol; 2011 Oct; 61(1):23-31. PubMed ID: 21651950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.